Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes

Toshiaki Takahashi, Elisabeth A. Morris, Stephen Trippel

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Insulin-like growth factor-I (IGF-I) is thought to play an important role in skeletal growth and development through its mitogenic and anabolic effects on epiphyseal growth plate chondrocytes. The bone morphogenetic proteins (BMPs) have been shown to promote endochondral osteogenesis, and some members of the BMP family, including BMP-2 and BMP-9, have anabolic effects on chondrocyte metabolism. We tested the hypothesis that BMP-2 and BMP-9 interact with IGF-I to modulate growth plate chondrocyte mitotic activity. IGF-I, but neither BMP-2 nor BMP-9, stimulated chondrocyte DNA synthesis. However, both BMP-2 and BMP-9 augmented the mitogenic action of IGF-I. BMP-2, but not BMP-9 increased IGF-I binding to growth plate chondrocytes in kinetic studies. In affinity labeling studies, 125I-IGF-I predominantly labeled an Mr ∼135-kDa moiety, consistent with the α subunit of the type 1 IGF receptor and an Mr ∼250-kDa moiety consistent with the type 2 IGF receptor. 125I-IGF-I labeling also appeared at Mr ∼43 kDa, consistent with 125I-IGF-I binding to insulin-like growth binding protein-3. Treatment of chondrocytes with BMP-2, but not with BMP-9, increased the intensity of the Mr ∼135-kDa band and decreased the intensity of the Mr ∼43-kDa band. Taken together, these data suggest that the BMPs may modulate the action of IGF-I via the type 1 IGF receptor and/or IGF binding proteins.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalInternational Journal of Molecular Medicine
Volume20
Issue number1
StatePublished - Jul 2007

Fingerprint

Growth Differentiation Factor 2
Bone Morphogenetic Protein 2
Growth Plate
Chondrocytes
Insulin-Like Growth Factor I
Bone Morphogenetic Proteins
Anabolic Agents
IGF Type 1 Receptor
IGF Type 2 Receptor
Insulin-Like Growth Factor Binding Proteins
Growth and Development
Osteogenesis
Carrier Proteins

Keywords

  • Bone morphogenetic proteins
  • Growth plate chondrocytes
  • Insulin-like growth factor-I

ASJC Scopus subject areas

  • Genetics

Cite this

Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes. / Takahashi, Toshiaki; Morris, Elisabeth A.; Trippel, Stephen.

In: International Journal of Molecular Medicine, Vol. 20, No. 1, 07.2007, p. 53-57.

Research output: Contribution to journalArticle

@article{595da55d7b584125afb59e90d8c6db49,
title = "Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes",
abstract = "Insulin-like growth factor-I (IGF-I) is thought to play an important role in skeletal growth and development through its mitogenic and anabolic effects on epiphyseal growth plate chondrocytes. The bone morphogenetic proteins (BMPs) have been shown to promote endochondral osteogenesis, and some members of the BMP family, including BMP-2 and BMP-9, have anabolic effects on chondrocyte metabolism. We tested the hypothesis that BMP-2 and BMP-9 interact with IGF-I to modulate growth plate chondrocyte mitotic activity. IGF-I, but neither BMP-2 nor BMP-9, stimulated chondrocyte DNA synthesis. However, both BMP-2 and BMP-9 augmented the mitogenic action of IGF-I. BMP-2, but not BMP-9 increased IGF-I binding to growth plate chondrocytes in kinetic studies. In affinity labeling studies, 125I-IGF-I predominantly labeled an Mr ∼135-kDa moiety, consistent with the α subunit of the type 1 IGF receptor and an Mr ∼250-kDa moiety consistent with the type 2 IGF receptor. 125I-IGF-I labeling also appeared at Mr ∼43 kDa, consistent with 125I-IGF-I binding to insulin-like growth binding protein-3. Treatment of chondrocytes with BMP-2, but not with BMP-9, increased the intensity of the Mr ∼135-kDa band and decreased the intensity of the Mr ∼43-kDa band. Taken together, these data suggest that the BMPs may modulate the action of IGF-I via the type 1 IGF receptor and/or IGF binding proteins.",
keywords = "Bone morphogenetic proteins, Growth plate chondrocytes, Insulin-like growth factor-I",
author = "Toshiaki Takahashi and Morris, {Elisabeth A.} and Stephen Trippel",
year = "2007",
month = "7",
language = "English",
volume = "20",
pages = "53--57",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Bone morphogenetic protein-2 and -9 regulate the interaction of insulin-like growth factor-I with growth plate chondrocytes

AU - Takahashi, Toshiaki

AU - Morris, Elisabeth A.

AU - Trippel, Stephen

PY - 2007/7

Y1 - 2007/7

N2 - Insulin-like growth factor-I (IGF-I) is thought to play an important role in skeletal growth and development through its mitogenic and anabolic effects on epiphyseal growth plate chondrocytes. The bone morphogenetic proteins (BMPs) have been shown to promote endochondral osteogenesis, and some members of the BMP family, including BMP-2 and BMP-9, have anabolic effects on chondrocyte metabolism. We tested the hypothesis that BMP-2 and BMP-9 interact with IGF-I to modulate growth plate chondrocyte mitotic activity. IGF-I, but neither BMP-2 nor BMP-9, stimulated chondrocyte DNA synthesis. However, both BMP-2 and BMP-9 augmented the mitogenic action of IGF-I. BMP-2, but not BMP-9 increased IGF-I binding to growth plate chondrocytes in kinetic studies. In affinity labeling studies, 125I-IGF-I predominantly labeled an Mr ∼135-kDa moiety, consistent with the α subunit of the type 1 IGF receptor and an Mr ∼250-kDa moiety consistent with the type 2 IGF receptor. 125I-IGF-I labeling also appeared at Mr ∼43 kDa, consistent with 125I-IGF-I binding to insulin-like growth binding protein-3. Treatment of chondrocytes with BMP-2, but not with BMP-9, increased the intensity of the Mr ∼135-kDa band and decreased the intensity of the Mr ∼43-kDa band. Taken together, these data suggest that the BMPs may modulate the action of IGF-I via the type 1 IGF receptor and/or IGF binding proteins.

AB - Insulin-like growth factor-I (IGF-I) is thought to play an important role in skeletal growth and development through its mitogenic and anabolic effects on epiphyseal growth plate chondrocytes. The bone morphogenetic proteins (BMPs) have been shown to promote endochondral osteogenesis, and some members of the BMP family, including BMP-2 and BMP-9, have anabolic effects on chondrocyte metabolism. We tested the hypothesis that BMP-2 and BMP-9 interact with IGF-I to modulate growth plate chondrocyte mitotic activity. IGF-I, but neither BMP-2 nor BMP-9, stimulated chondrocyte DNA synthesis. However, both BMP-2 and BMP-9 augmented the mitogenic action of IGF-I. BMP-2, but not BMP-9 increased IGF-I binding to growth plate chondrocytes in kinetic studies. In affinity labeling studies, 125I-IGF-I predominantly labeled an Mr ∼135-kDa moiety, consistent with the α subunit of the type 1 IGF receptor and an Mr ∼250-kDa moiety consistent with the type 2 IGF receptor. 125I-IGF-I labeling also appeared at Mr ∼43 kDa, consistent with 125I-IGF-I binding to insulin-like growth binding protein-3. Treatment of chondrocytes with BMP-2, but not with BMP-9, increased the intensity of the Mr ∼135-kDa band and decreased the intensity of the Mr ∼43-kDa band. Taken together, these data suggest that the BMPs may modulate the action of IGF-I via the type 1 IGF receptor and/or IGF binding proteins.

KW - Bone morphogenetic proteins

KW - Growth plate chondrocytes

KW - Insulin-like growth factor-I

UR - http://www.scopus.com/inward/record.url?scp=34548062426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548062426&partnerID=8YFLogxK

M3 - Article

C2 - 17549388

AN - SCOPUS:34548062426

VL - 20

SP - 53

EP - 57

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 1

ER -